Johnson & Johnson's DePuy Synthes received the European CE Mark for its Bi-Mentum Dual Mobility System used in hip surgeries, according to Med-Tech Innovation.
What you should know:
1. Intended for use in patients with a higher risk of dislocation, the Bi-Mentum system features a standard femoral head articulating within a large polyethylene liner, which swivels inside a metal shell.
2. Bi-Mentum is already available in the U.S. It is expected to make its debut in European markets in April.
3. DePuy's dual-mobility acetabular cups have been implanted in 165,000 cases since 2007.
4. The rate of instability caused by dislocation after total hip arthroplasty is as high as 7 percent in the primary setting and 25 percent in the revision setting. Surgically treating a dislocation after THA can increase hip replacement costs by 342 percent.